Fed. Circ. Wary Of Undoing Endo Loss Over Vasostrict Fight
Two Federal Circuit judges on Thursday repeatedly pushed back on an Endo International unit's assertion that a Delaware federal judge erroneously declined to stop Eagle Pharmaceuticals Inc. from launching a generic...To view the full article, register now.
Already a subscriber? Click here to view full article